[1]JI M,ZHANG JP,LI JS.Clinical features of Dubin-Johnson syndrome[J].J Clin Hepatol,2013,29(4):319-320.(in Chinese)姬蒙,张金平,李建生.Dubin-Johnson综合征的临床特点分析[J].临床肝胆病杂志,2013,29(4):319-320.
|
[2]DUBIN IN,JOHNSON FB.Chronic idiopathic jaundice with unidentified pigment in liver cells:a new clinicopathologic entity with a report of 12 cases[J].Medicine(Baltimore),1954,33(3):155-197.
|
[3]HASHIMOTO K,UCHIUMI T,KONNO T,et al.Trafficking and functional defects by mutations of the ATP-binding domains in MRP2 in patients with Dubin-Johnson syndrome[J].Hepatology,2002,36(5):1236-1245.
|
[4]IKEMURA K,IWAMOTO T,OKUDA M.Altered functions and expressions of drug transporters in liver,kidney and intestine in disorders of local and remote organs:possible role of oxidative stress in the pathogenesis[J].Expert Opin Drug Metab Toxicol,2009,5(8):907-920.
|
[5]QOSA H,MILLER DS,PASINELLI P,et al.Regulation of ABCefflux transporters at blood-brain barrier in health and neurological disorders[J].Brain Res,2015,1628(Pt B):298-316.
|
[6]UCHIUMI T,TANAMACHI H,KUCHIWAKI K,et al.Mutation and fuctional analysis of ABCC2/multidrug resistance protein 2 in a Japanese patient with Dubin-Johnson syndrome[J].Hepatol Res,2013,43(5):569-575.
|
[7]STRASSBURG CP.Hyperbilirubinemia syndromes(Gilbert-Meulengracht,Crigler-Najjar,Dubin-Johnson,and Rotor Syndrome)[J].Best Pract Res Clin Gastroenterol,2010,24(5):555-571.
|